J. Goldman & Co’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 470 |
|
|
2025
Q1 | – | Sell |
-87,866
| Closed | -$10.7M | – | 465 |
|
|
2024
Q4 | $10.7M | Sell |
87,866
-11,372
| -11% | -$1.38M | 0.28% | 87 |
|
|
2024
Q3 | $12.4M | Buy |
99,238
+55,585
| +127% | +$6.94M | 0.35% | 62 |
|
|
2024
Q2 | $6.9M | Buy |
+43,653
| New | +$6.9M | 0.2% | 107 |
|
|
2023
Q3 | – | Sell |
-1,775
| Closed | -$203K | – | 349 |
|
|
2023
Q2 | $203K | Buy |
+1,775
| New | +$203K | 0.01% | 215 |
|
|
2019
Q4 | – | Sell |
-70,947
| Closed | -$5.34M | – | 252 |
|
|
2019
Q3 | $5.34M | Buy |
+70,947
| New | +$5.34M | 0.4% | 46 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 253 |
|
|
2018
Q2 | – | Sell |
-43,767
| Closed | -$3.24M | – | 320 |
|
|
2018
Q1 | $3.24M | Sell |
43,767
-23,124
| -35% | -$1.71M | 0.14% | 109 |
|
|
2017
Q4 | $3.72M | Sell |
66,891
-37,632
| -36% | -$2.09M | 0.2% | 77 |
|
|
2017
Q3 | $4.74M | Buy |
104,523
+70,423
| +207% | +$3.19M | 0.24% | 66 |
|
|
2017
Q2 | $1.15M | Buy |
34,100
+25,600
| +301% | +$863K | 0.06% | 119 |
|
|
2017
Q1 | $252K | Sell |
8,500
-91,400
| -91% | -$2.71M | 0.01% | 182 |
|
|
2016
Q4 | $2.74M | Buy |
99,900
+95,525
| +2,183% | +$2.62M | 0.18% | 84 |
|
|
2016
Q3 | $269K | Sell |
4,375
-85,800
| -95% | -$5.28M | 0.02% | 174 |
|
|
2016
Q2 | $1.72M | Buy |
+90,175
| New | +$1.72M | 0.09% | 112 |
|
|
2015
Q4 | – | Sell |
-1,813
| Closed | -$58K | – | 222 |
|
|
2015
Q3 | $58K | Buy |
+1,813
| New | +$58K | 0.01% | 140 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 201 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 226 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 181 |
|